Fig. 1

Therapeutic perspectives of GLP-1 combined with MSCs in T2DM and Its Complications
GLP-1 modulates MSCs derived from various tissues and organs of the body by means of pre-treatment of MSCs, gene editing, embedding in biomaterials and peptide chain modification. This combination of treatments has been shown to be effective in injuries to the liver, kidneys, heart, lungs, skin and bone